Producing micron- And nano- size formulations for functional foods applications

Functional Foods in Health and Disease

Volumn 3, Issue 7, 2013, Pages 274-289

  Panagiotou, Thomai ^a   Fisher, Robert J ^b  

^a IDEX Material Processing Technologies   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Crystallization; Curcumin; Fish oil; High shear processing; Liposomal vitamins: C and E; Lutein; Nano emulsion; Nano suspension; Nutraceuticals; Omega 3; Soybean fiber

Indexed keywords

EID: 84888877852     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v3i7.48     Document Type: Article

References (53)

1. Berdanier C. Advanced Nutrition Micronutrients. 1997; CRC Press ISBN 0849326648, pp 27-9
2. Chow CK. Fatty Acids in Food and their Health Implications. 2001; Routledge Publ. New York, NY
3. Merisko-Liversidge E, Liversidge G, Cooper E. Nanosizing: A Formulation Approach For Poorly-Water-Soluble Compounds. Eur. J. Pharm. Sci. 2003; 18:113-123.
4. Rabinow BE. Nanosuspensions in Drug Delivery. Nature Reviews Drug Discovery 2004; 3(9): 785-796.
5. Rabinow BE. Pharmacokinetics of Nanosuspensions, Proceedings of the Nanotechnology for Drug Delivery Conference 2005; Philadelphia, Pa, USA.
6. Panagiotou T, Fisher RJ. Form Nano-Particles Via Controlled Crystallization: A“Bottom-Up” Approach. Chem. Eng. Prog. 2008; 104(10): 33-39.
7. Panagiotou T, Mesite S, Fisher RJ. Production Of Norfloxacin Nano-Suspensions Using Microfluidics Reaction Technology (MRT) Through Solvent/Anti-Solvent Crystallization. Ind. Eng. Chem. Res. 2009; 48(4): 1761-1771.
8. Liversidge GG. Controlled Release And Nanotechnologies: Recent Advances And Future Opportunities. Drug Development and Delivery 2011; 11: 1-7.
9. Panagiotou T, Fisher RJ. Enhanced Transport Capabilities via Nanotechnologies: Impacting Bio-efficacy, Controlled Release Strategies and Novel Chaperones. J. Drug Delivery 2011; ID 902403, 1-14.
10. Panagiotou T, Fisher RJ. Improving Product Quality with Entrapped Stable Emulsions: From Theory to Industrial Application. Challenges 2012; Vol. 3: 1-39.
11. Okushima S, Nisisako T, Torii T, Higuchi T. Controlled Production Of Monodisperse Double Emulsions by Two Step Droplet Breakup in Microfluidic Devices. Langmuir 2004; 20: 9905-9908.
12. Hakansson A, Innings F, Tragardh C, Bergenstahl B. A High-Pressure Homogenization Emulsification Model-Improved Emulsifier Transport And Hydrodynamic Coupling. Ch Eng Sci 2013; 91: 44-53.
13. Lasic DD. Liposomes In Gene Delivery. 1997 CRC Press LLC, Boca Raton, FL.
14. Drusch S, et al. Stabilization of Omega-3 fatty Acids by Microencapsulation. Agro FOOD 2008;19(4): 31-32.
15. Mozaffarain D, Rimm EB. Fish Intake, Contaminates, and Human Health: Evaluating the Risks and Benefits. JAMA 2000; 296(15): 1885-1899.
16. Huang Q. Micro/nanoencapsulation of Active Food Ingredients. American Chemical Society, proceedings of ACS Symposium Series XIV, Washington, DC, 2009; 314(1): 8.
17. Soottitantawat A. Microencapsulation by Spray Drying: Influence of Emulsion Size on the Retention of Volatile Compounds. Journal of Food Science 2003; 68(7): 2256-2262.
18. Hogan SA. Microencapsulating Properties of Sodium Caseinate. Journal of Agricultural and Food Chemistry 2001; 49(4): 1934-1938.
19. Ma Y, Reineccius GA. The Stability of Spray-Dried Microcapsules as a Function of Glass Transition Temperature. Proceedings of the Institute of Food Technologists Annual Meeting, New Orleans, LA, June 1992; 17-18.
20. Kjaergaard OG. Multiple-Core Encapsulation. Microencapsulation of Food Ingredients, VP, Editor, Leatherhead, Surrey, UK, 2001; 133-144.
21. Keogh MK. Stability to Oxidation of Spray-Dried Fish Oil Powder Microencapsulated Using Milk Ingredients. J. Food Sci. 2001; 66(2): 217-224.
22. Drusch S, Serfert Y, Schwarz K. Microencapsulation of Fish Oil with N-Octenylsuccinate-Derivatised Starch: Flow Properties and Oxidative Stability. European Journal of Lipid Science and Technology 2006; 108(6):501-512.
23. Miller MT. In Vitro Evaluation of Cytotoxicity and Cellular Uptake of Alternating Copolymers for use as Drug Delivery Vehicles. Ph.D. Dissertation, Department of Chemical Engineering, Massachusetts Institute of Technology, June 2009.
24. Gomez-Hens A, Fernandez-Romero JM. Analytical Methods For The Control of Liposomal Delivery Systems. Trends Anal Chem 2006; 25: 167-178.
25. Mozafari MR, Johnson C, Hatziantoniou S, Demetzos C. Nanoliposomes And Their Applications In Food Nanotechnology. J. Liposome Res. 2008; 18(4): 309-327.
26. Mozafari MR, Mortazavi SM. Nanoliposomes: From Fundamentals To Recent Developments. 2005; Trafford Publishing Ltd, Oxford, UK.
27. Bender DA. Nutritional Biochemistry Of Vitamins 2003; Cambridge, UK.
28. Bowen PE, Herbst-Espinosa SM, Hussain EA, Stacewicz-Sapuntzakis M. Esterification Does Not Impair Lutein Bioavailability In Humans. J. Nutr. 2002; 132(12) 3668-3673.
29. Johnson EJ, Hammond BR, Yeum KJ. Relation Among Serum And Tissue Concentrations Of Lutein Andzeaxanthin And Macular Pigment Density. Am J. Clin Nutr. 2000; 71(6): 1555-62.
30. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional Manipulation Of Primate Retinas, III: Effects Of Lutein Or Zeaxanthin Supplementation on Adipose Tissue And Retina Of Xanthophyll-Free Monkeys. Invest. Ophthalmol. Vis. Sci. 2005; 46(2): 692-702.
31. Richer S, Stiles W, Statkute L. Double-Masked, Placebo-Controlled, Randomized Trial of Lutein And Antioxidant Supplementation. Optometry 2004; 75(4): 216-30.
32. SanGiovanni JP, Chew EY, Clemons TE. The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22. Arch. Ophthalmol. 2007; 125(9): 1225-1232.
33. Baker FM. Dietary Supplementation: Effects nn Visual Performance and Occurance of Amd And Cataracts. Current Medi. Res. and Opinion 2010; 26(8): 2011-2023.
34. Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmerman BN. The Effect of Turmeric Extracts on Inflammatory Mediator Production. Phytomedicine 2005; 12: 445-452.
35. Kunchandy E, Rao, MNA. Oxygen Radical Scavenging Activity Of Curcumin. Int. J. Pharm. 1990; 58: 237-240.
36. Sharma RA, Gescher AJ, Steward WP. Curcumin: The Story So Far. Eur. J. Cancer 2005; 14: 1955-1968.
37. Khanna NM. Turmeric: Nature's Precious Gift. Curr. Sci. 1999; 76: 1351-1356.
38. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A Potential Role of the Curry Spice Curcumin in Alzheimer's Disease. Curr Alzheimer Res. 2005; 2: 131- 136.
39. Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM, Timmerman BN. Turmeric Extracts Containing Curcuminoids Prevent Experimental Rheumatoid Arthritis. J. Nat. Prod. 2006; 69: 351-355.
40. Donsi F, Wang Y, Li J, Huang Q. Preparation of Curcumin Sub-micrometer Dispersions by High-Pressure Homogenization. J. Agric. Food Chem. 2010; 58: 2848-2853.
41. Onque S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmerman B, Yamada S. Formulation Design And Photochemical Studies On Nanocrystal Solid Dispersion of Curcumin With Improved Oral Bioavailability. J. Pharma. Sci. 2010; 99(4): 1871-1881.
42. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid Complex: Preparation, Therapeutic Evaluation and Pharmacokinetic Study In Rats. Int. J. Pharm. 2007; 330: 155-163.
43. Sharma RA, Gescher AJ, Steward WP. Curcumin: The Story So Far. Eur. J. Cancer 2005; 41: 1961-1969.
44. Tonnesen HH, Karlsen J, van Henegouwen GB. Chemistry of Curcumin and Curcuminoids. Z. Lebensm Unters Forsch 1986; 183: 116-122.
45. Chen C, Johnston TD, Jeon H, Gedaly R, McHugh PP, Burke TG, Ranjan D. An In Vitro Study of Liposomal Curcumin: Stability, Toxicity And Biological Activity In Human Lymphocytes And Epstein-Barr Virus-Transformed Human B-Cells. Int. J. Pharm. 2009; 366: 133-139.
46. Tonnesen HH, Masson M, Loftsson T. Studies Of Curcumin and Curcuminoids. XXVII. Cyclodextrin Complexation: Solubility, Chemical And Photochemical Stability. Int. J.Pharm. 2002; 244: 127-135.
47. Tomren MA, Masson M, Loftsson T, Tonnesen HH. Studies on Curcumin and Curcuminoids. XXXI. Symmetric and Asymmetric Curcuminoids: Stability, Activity and Complexation with Cyclodextrin. Int. J. Pharm. 2007; 338: 27-34.
48. Letchford K, Liggins R, Burt H. Solubilization of Hydrophobic Drugs by Methoxy Poly(Ethylene Glycol)-Block-Polycaprolactone Diblock Copolymer Micelles: Theoretical and Experimental Data And Correlations. J. Pharma. Sci. 2008; 97: 1179-1190.
49. Ravindranath V, Chandrasekhara N. Absorption and Tissue Distribution of Curcumin in Rats. Toxicology 1980; 16: 259-265.
50. Cheng A, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Wu MS, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-Risk or Pre-Malignant Lesions. Anticancer Res. 2001; 21: 2895-2900.
51. Pan MH, Huang TM, Lin JK. Biotransformation Of Curcumin Through Reduction and Glucuronidation in Mice. Drug Metab. Dispos. 1999; 27: 486-494.
52. He Y, Huang Y, Cheng Y. Structure Evolution of Curcumin Nanoprecipitation from a Micromixer. Crystal Growth and Design/Comm. 2010; 10: 1021-1027.
53. US Patent No. 8187554; Apparatus and Methods for Nano-Particle Generation and Process Intensification of Transport and Reaction Systems. May 2012.